| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
4 companies
Lyons Gary A is a Director at NBIX, with reported holdings spanning 4 companies. Recent filings cover 0 purchases and 31 sales. Those positions are worth an estimated $3.9M at current prices.
Our model assigns Lyons Gary A a middling insider score of 54/100, based on 14 past trades. Over a 12-month horizon, 38.5% of those trades were profitable, with an average 12-month return of -4.9%.
Lyons Gary A's largest disclosed position is in TVTX as Director, worth about $3.9M. The recent filings there lean toward selling, a net 58,000 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Nov 2, 2018 | NBIX Neurocrine Biosciences Inc | Director | Sell | 15,000 | $114.41 | $1,716,213.00 | -5.8% | |
| Jun 13, 2018 | NBIX Neurocrine Biosciences Inc | Director | Sell | 15,000 | $99.24 | $1,488,549.00 | -5.4% | |
| Feb 15, 2018 | NBIX Neurocrine Biosciences Inc | Director | Sell | 5,000 | $84.67 | $423,341.00 | -1.9% | |
| Feb 5, 2018 | NBIX Neurocrine Biosciences Inc | Director | Sell | 5,000 | $83.08 | $415,380.00 | -1.8% | |
| Dec 1, 2017 | NBIX Neurocrine Biosciences Inc | Director | Sell | 10,000 | $72.92 | $729,182.00 | -3.5% |